Study of Contributing Factors for Cure Response in Patients with Acute Myeloblastic Leukemia （AML）
Study of Contributing Factors for Cure Response in Patients with Acute Myeloblastic Leukemia （AML）
参考文献28
-
1J.W. Vardiman, N.L. Harris, R.D. Brunning, The World Health Organization (WHO) classification of the myeloid neoplasms, Blood 100 (7) (2002): 2292-2302.
-
2M.L. Smith, J.D. Cavenagh, T.A. Lister, J. Fitzgibbon, Mutation of CEBPA in familial acute myeloid leukemia, The New England Journal of Medicine 351(23) (2004): 2403 -2407.
-
3J.M. Ribera, A. Oriol, Acute lymphoblastic leukemia in adolescents and young adults, Hematology/Oncology Clinics of North America 23 (5) (2009) :1033-1042.
-
4D. Campana, Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia, Hematology/Oncology Clinics of North America 23 (5) (2009): 1083-1098.
-
5P.S. Gaynon, Childhood acute lymphoblastic leukaemia and relapse, British Journal of Haematology 131 (5) (2005): 579-587.
-
6J.H. Kersey, Fifty years of studies of the biology and therapy of childhood leukemia, Blood 92 (5) (1998) :1838.
-
7I.J. Griswold, L.J. Shen, P. La Rosee, S. Demehri, M.C. Heinrich, R.M. Braziel, et al., Effects ofMLNSIS, a dual FLT3 and KIT inhibitor, on normal and malignant hematopoiesis, Blood 104 (9) (2004) :2912-2918.
-
8J.P. Neglia, L.L. Robison, Epidemiology of the childhood acute leukemias, Pediatric Clinics of North America 35(4) (1988) :675-692.
-
9S.W. Goldman, J.S. Holcenberg, J.Z. Finklestein, R. Hutchinson, S. Kreissman, F. L. Johnson, et al., A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis, Blood 97 (10) (2001): 2998-3003.
-
10C.H. Pui, W.E. Evans, Treatment of acute lymphoblastic leukemia, The New England Journal of Medicine 354 (2) (2006): 166-178.
-
1崔秀娜,袁丽钗,苏晓娟,吴祥云,王海英,卢善发.miR1444a参与毛果杨对锌胁迫的响应[J].中国科学：生命科学,2012,42(10):850-860. 被引量：4
-
2Katherine Darner.Steps To ward HIV Cure Two more HIV-infected patients appear to be virus-free after bone-marrow transplants[J].ChinAfrica,2013,5(8):58-58.
-
3LIN Yan-ping,YIN Wen-jin,YAN Ting-ting,ZHOU Li-heng,DI Geng-hong,WU Jiong,SHEN Zhen-zhou,SHAO Zhi-min,LU Jin-song.Risk factors for postoperative seromas in Chinese breast cancer patients[J].Chinese Medical Journal,2011(9):1300-1304. 被引量：2
-
4王英泽,贾青,常万存.应用LOGISTIC回归分析山羊胚胎移植妊娠率影响因素的研究[J].河北农业大学学报,2006,29(1):87-90.
-
5Yang Gao,Yanqing Zhao,Jianpeng Liu,Ming Zhou,Heyuan Liu,Fang Liu,Wenyu Yang,Dekun Chen.Orf in Goats in China： Prevalence and Risk Factors[J].Journal of Agricultural Science and Technology(A),2016,6(2):116-123.
-
6Jun Tang.How close is the stem cell cure to the Alzheimer's disease Future and beyond?[J].Neural Regeneration Research,2012,7(1):66-71. 被引量：2
-
7方妙弦,熊卫萍,曾嵘,于长江,李欣,范瑞新.Risk factors for thepostoperative cerebral complicationin patients with acute type A aortic dissection[J].South China Journal of Cardiology,2015,16(4):208-214.
-
8刘君,朱良其,黑银秀,刘灿,谢菲,何道根.西兰花苗期生长模型的拟合和分析[J].浙江农业学报,2016,28(12):2040-2046. 被引量：11
-
9Dongfeng Gu,Youming Chen,Zhiyong Yuan,Xinyu Liu,Yongqiang Li,Xiaofei Shao,Yan Liang,Hequn Zou.Epidemic Study of Chronic Kidney Disease and Prediabetes[J].器官移植内科学杂志,2015,10(1):5-16.
-
10Yongchang Chen Yuyu Niu Weizhi Ji.Transgenic Nonhuman Primate Models for Human Diseases:Approaches and Contributing Factors[J].Journal of Genetics and Genomics,2012,39(6):247-251. 被引量：5
